Wildner, O <br/><br/>
Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.  [electronic resource] 

 -  Human gene therapy  Nov 1999 
 - 2679-87 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1043-0342 
<br/><br/><label>Standard No.: </label>10.1089/10430349950016726  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Antiviral Agents--pharmacology<br/>Carcinogenicity Tests<br/>Carcinoma--drug therapy<br/>Colonic Neoplasms--drug therapy<br/>Drug Synergism<br/>Enzyme Inhibitors--administration & dosage<br/>Female<br/>Ganciclovir--administration & dosage<br/>Humans<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Mice, Nude<br/>Prodrugs--administration & dosage<br/>Simplexvirus--enzymology<br/>Survival Rate<br/>Thymidine Kinase--genetics<br/>Topoisomerase I Inhibitors<br/>Topotecan--administration & dosage<br/>Transplantation, Heterologous<br/>Tumor Cells, Cultured